Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

32.16
-1.7000-5.02%
Post-market: 32.300.1400+0.44%19:57 EDT
Volume:2.38M
Turnover:77.36M
Market Cap:3.75B
PE:-6.89
High:33.86
Open:33.75
Low:31.98
Close:33.86
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:1.37
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.19
PE(LYR):-10.08

Loading ...

Jul 28, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 08, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Feb 17, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 17, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Major Issues Report

8-K - Current report
Oct 28, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2020

Major Issues Report

8-K - Current report
Aug 28, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2020

Major Issues Report

8-K - Current report
May 21, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Major Issues Report

8-K - Current report
Apr 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]